MS4A7: A Potential Drug Target and Biomarker (G58475)

Target Name: MS4A7

NCBI ID: G58475

MS4A7

MS4A7: A Potential Drug Target and Biomarker

MS4A7 (Four-span transmembrane protein 2) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and various functions make it an attractive target for drug development. In this article, we will discuss the structure and function of MS4A7, its potential as a drug target, and its potential as a biomarker.

Structure and Function

MS4A7 is a four-span transmembrane protein that consists of four distinct regions: N-terminal, C-terminal, D-terminal, and E-terminal. The N-terminal region contains a unique farnesylated cysteine residue, which is a hallmark of the protein. The C-terminal region contains a conserved Asp209 residue, which is involved in the regulation of protein stability. The D-terminal region contains a unique Glu215 residue that is involved in protein-protein interactions. The E-terminal region contains a Gly217 residue that is involved in the regulation of protein stability.

MS4A7 is a protein that is expressed in various tissues and cells, including the brain, heart, liver, and pancreas. Its functions include cell signaling, protein-protein interactions, and modulation of protein stability. MS4A7 has been shown to play a role in various cellular processes, including cell signaling, cell adhesion, and neurotransmission.

Potential Drug Target

MS4A7 has been identified as a potential drug target due to its unique structure and various functions. Its N-terminal region is farnesylated, which is a hallmark of protein stability. This suggests that modifying the N-terminal region may be a useful strategy for drug development. Additionally, MS4A7 has been shown to play a role in various cellular processes, including cell signaling, cell adhesion, and neurotransmission. This suggests that targeting MS4A7 may be a useful strategy for treating diseases that are related to these processes.

Potential Biomarker

MS4A7 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because its unique structure and various functions make it an attractive target for diagnostic tools. For example, its N-terminal region is farnesylated, which can be used as a marker for neurodegenerative diseases. Additionally, its unique structure and functions make it an attractive target for cancer and autoimmune disorders.

Conclusion

MS4A7 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and various functions make it an attractive target for drug development. Additionally, its potential as a biomarker for various diseases makes it an attractive target for diagnostic tools. Further research is needed to fully understand its functions and potential as a drug target and biomarker.

Protein Name: Membrane Spanning 4-domains A7

Functions: May be involved in signal transduction as a component of a multimeric receptor complex

The "MS4A7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MS4A7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets